Citalopram Hydrobromide
Citalopram Hydrobromide is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Citalopram Hydrobromide; Generic name: CITALOPRAM HYDROBROMIDE; Manufacturer: Glenmark Therapeutics Inc., USA.
| Brand name | Citalopram Hydrobromide |
|---|---|
| Generic name | CITALOPRAM HYDROBROMIDE |
| Manufacturer | Glenmark Therapeutics Inc., USA |
| Used for | 1 INDICATIONS AND USAGE Citalopram tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies ( 14 )] . Citalopram tablets are a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of major depressive disorder (MDD) in adults ( 1 ). |
| Dosage | 2 DOSAGE AND ADMINISTRATION • Administer once daily with or without food ( 2 ). • Initial dosage is 20 mg once daily; after one week may increase to maximum dosage of 40 mg once daily ( 2.1 ). • Patients greater than 60 years of age, patients with hepatic impairment, and CYP2C19 poor metabolizers: maximum recommended dosage is 20 mg once daily ( 2.2 ) . • When discontinuing citalopram tablets, reduce dosage gradually ( 2.4 , 5.6 ) . 2.1 Recommended Dosage Administer citalopram tablets once daily |
| Warnings | WARNING: SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors [see Warnings and Precautions ( 5.1 )] . Citalopram is not approved for use in pediatric patients [see Use in Specific Populations ( 8.4 )] . WARNING: SUICIDAL THOUGHTS AND BEHAVIORS See full prescri |
| Active ingredient(s) | CITALOPRAM HYDROBROMIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=18330b41-27ad-461b-a0a9-aac94e8ee87f |